44 /100
MEDIUM RISK
Score updated Jun 11, 2026

INKT — MiNK Therapeutics, Inc. Dilution Risk Tracker

Track INKT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INKT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
65
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for INKT.
🔔 Track INKT — Get forecast alerts →

💹 Market Data

Market Cap$60.78M
Shares Outstanding4.98M
Float1.96M
Cash$9.53M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 416.1% shares (2025Q4 vs prior)
1 institutional holders · 160 shares
#1 HORIZON FINANCIAL SERVICES, LLC 160 shares

📉 Short Interest

Short Interest123.0K
Days to Cover4.4
% of Float6.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track INKT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INKT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for INKT
📊 INKT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 INKT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.